Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease
- PMID: 577211
- PMCID: PMC372323
- DOI: 10.1172/JCI108734
Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease
Abstract
Previous studies have suggested that there is an overproduction of triiodothyronine (T(3)) relative to thyroxine (T(4)) in patients with thyrotoxicosis associated with Graves' disease. To evaluate whether or not an increased ratio of T(3) to T(4) in thyroidal secretion could be contributing to this relative T(3) hyperproduction, T(3), T(4), and iodine were measured in thyroglobulin (Tg) from controls and patients with Graves' disease who had been treated either with propranolol only or with antithyroid drugs plus iodide before surgery. To avoid possible artifacts associated with pulse labeling and chromatography, T(3) and T(4) were determined by radioimmunoassay of Pronase hydrolysates of purified Tg. Results of analyses of Tg from six control patients and seven with Graves' disease, not receiving thiourea drugs or iodide, showed that the iodine content of Graves' disease Tg was not different from normal. Both contained 3.4 residues of T(4)/molecule Tg, but there was 0.39+/-0.08 (mean+/-SD) residue of T(3)/molecule Tg in Graves' Tg as opposed to 0.23+/-0.07 residue T(3) molecule Tg in controls matched for iodine content (P < 0.01). This difference resulted in a significantly lower T(4)/T(3) molar ratio (9+/-2) in Graves' Tg as opposed to control (15+/-2, P < 0.001). In Tg from patients with treated Graves' disease, iodine, T(3), and T(4) were reduced, but the reduction in the latter was more substantial, resulting in a T(4)/T(3) molar ratio of 3.4+/-1. Fractionation of Tg from all groups by RbCl density gradient ultracentrifugation indicated that at physiological levels of Tg iodination, the molar ratio of T(3)/Tg was consistently higher in Graves' disease. The specific mechanism for this difference is not known, but it is not due to iodine deficiency. If T(3) and T(4) are secreted in this altered ratio in patients with Graves' disease, the magnitude of the difference could explain the relative T(3) hyperproduction which is characteristic of this state.
Similar articles
-
Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.J Clin Endocrinol Metab. 1975 Dec;41(06):1098-104. doi: 10.1210/jcem-41-6-1098. J Clin Endocrinol Metab. 1975. PMID: 54364
-
Iodinating activity of thyroid tissue in toxic diffuse goiter.J Clin Invest. 1977 Apr;59(4):723-9. doi: 10.1172/JCI108691. J Clin Invest. 1977. PMID: 576614 Free PMC article.
-
Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.J Clin Endocrinol Metab. 1988 Jan;66(1):147-52. doi: 10.1210/jcem-66-1-147. J Clin Endocrinol Metab. 1988. PMID: 3335601
-
Mechanisms governing the relative proportions of thyroxine and 3,5,3'-triiodothyronine in thyroid secretion.Metabolism. 1984 Apr;33(4):379-92. doi: 10.1016/0026-0495(84)90203-8. Metabolism. 1984. PMID: 6369072 Review.
-
[Treatment with inorganic iodine for Graves' hyperthyroidism].Nihon Rinsho. 2006 Dec;64(12):2269-73. Nihon Rinsho. 2006. PMID: 17154090 Review. Japanese.
Cited by
-
Thyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil.J Clin Endocrinol Metab. 2024 Sep 16;109(10):2504-2512. doi: 10.1210/clinem/dgae139. J Clin Endocrinol Metab. 2024. PMID: 38506164
-
Plasticizers: negative impacts on the thyroid hormone system.Environ Sci Pollut Res Int. 2022 Jun;29(26):38912-38927. doi: 10.1007/s11356-022-19594-0. Epub 2022 Mar 18. Environ Sci Pollut Res Int. 2022. PMID: 35303231 Free PMC article. Review.
-
Cryo-EM structure of native human thyroglobulin.Nat Commun. 2022 Jan 10;13(1):61. doi: 10.1038/s41467-021-27693-8. Nat Commun. 2022. PMID: 35013249 Free PMC article.
-
The structure of natively iodinated bovine thyroglobulin.Acta Crystallogr D Struct Biol. 2021 Nov 1;77(Pt 11):1451-1459. doi: 10.1107/S2059798321010056. Epub 2021 Oct 29. Acta Crystallogr D Struct Biol. 2021. PMID: 34726172 Free PMC article.
-
De novo triiodothyronine formation from thyrocytes activated by thyroid-stimulating hormone.J Biol Chem. 2017 Sep 15;292(37):15434-15444. doi: 10.1074/jbc.M117.784447. Epub 2017 Jul 25. J Biol Chem. 2017. PMID: 28743746 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
